scholarly journals Acoustic deposition with NIMS as a high-throughput enzyme activity assay

2012 ◽  
Vol 403 (3) ◽  
pp. 707-711 ◽  
Author(s):  
Matthew Greving ◽  
Xiaoliang Cheng ◽  
Wolfgang Reindl ◽  
Benjamin Bowen ◽  
Kai Deng ◽  
...  
2019 ◽  
Vol 58 (30) ◽  
pp. 10114-10119 ◽  
Author(s):  
Tristan de Rond ◽  
Jian Gao ◽  
Amin Zargar ◽  
Markus de Raad ◽  
Jack Cunha ◽  
...  

2019 ◽  
Vol 131 (30) ◽  
pp. 10220-10225 ◽  
Author(s):  
Tristan de Rond ◽  
Jian Gao ◽  
Amin Zargar ◽  
Markus de Raad ◽  
Jack Cunha ◽  
...  

2011 ◽  
Vol 16 (5) ◽  
pp. 506-517 ◽  
Author(s):  
Paul Tawa ◽  
Jean-Pierre Falgueyret ◽  
Sebastien Guiral ◽  
Elise Isabel ◽  
David A. Powell ◽  
...  

Stearoyl-CoA desaturase (SCD) catalyzes the synthesis of monounsaturated fatty acids and has been implicated in a number of disease states, including obesity and diabetes. To find small-molecule inhibitor leads, a high-throughput scintillation proximity assay (SPA) was developed using the hydrophobic binding characteristics of a glass microsphere scintillant bead to capture SCD1 from a crude lysate of recombinant SCD1 in Sf9 lysate coupled with the strong binding characteristics of an azetidine compound ([3H]AZE). The SPA assay was stable over 24 h and could detect compounds with micromolar to nanomolar potencies. A robust 1536-well high-throughput screening assay was developed with good signal-to-noise ratio (10:1) and excellent Z′ factor (0.8). A screening collection of 1.6 million compounds was screened at 11 µM, and approximately 7700 compounds were identified as initial hits, exhibiting at least 35% inhibition of [3H]AZE binding. Further screening and confirmation with an SCD enzyme activity assay led to a number of new structural leads for inhibition of the enzyme. The SPA assay complements the enzyme activity assay for SCD1 as a tool for the discovery of novel leads in drug discovery.


2010 ◽  
Vol 31 (6) ◽  
pp. 499-503
Author(s):  
Hai-Jun ZHANG ◽  
Jun YANG ◽  
Xiao-Guang LIU ◽  
Xiang-Yang HU

2012 ◽  
Vol 105 (3) ◽  
pp. 404-407 ◽  
Author(s):  
Taiichi Wakiya ◽  
Yukihiro Sanada ◽  
Taizen Urahashi ◽  
Yoshiyuki Ihara ◽  
Naoya Yamada ◽  
...  

2021 ◽  
pp. 1-22
Author(s):  
Vijay K. Choudhary ◽  
Seshadri S. Reddy ◽  
Subhash K. Mishra ◽  
Bhumesh Kumar ◽  
Yogita Gharde ◽  
...  

Abstract Smallflower umbrella sedge is one of the problematic weeds in direct-seeded rice in India. Bispyribac-sodium (acetolactate synthase-inhibiting herbicide) is a commonly used in rice, but recently growers have reported lack of smallflower umbrella sedge control with this herbicide. An extensive survey was carried out in two rice growing states, Chhattisgarh and Kerala, where 53 putative bispyribac-sodium resistant (BR) biotypes were collected. Studies were conducted to confirm resistance to bispyribac-sodium and to test the efficacy of newly developed synthetic auxin herbicide florpyrauxifen-benzyl on putative BR biotypes. Whole-plant bioassay revealed that bispyribac-sodium is no longer effective. Of 53 putative BR biotypes, 17 biotypes survived recommended label rate of 25 g ai ha−1. Effective bispyribac-sodium rate required to control 50% of the plants in most of the BR biotypes (ED50) ranged from 19 to 96 g ha−1 whereas it was 10 g ha−1 in susceptible biotype. In two highly resistant biotypes, ED50 was beyond the maximum tested rate, 200 g ha−1. This suggests 2 to >20-fold resistance in BR biotypes. Acetolactate synthase (ALS) enzyme activity assay suggests altered target site as mechanism of resistance to bispyribac-sodium. This study confirms the first case of evolved resistance in smallflower umbrella sedge for bispyribac-sodium in India. However, the newly developed synthetic auxin, florpyrauxifen-benzyl effectively controlled all BR biotypes at the field use rate 31.25 g ae ha−1.


Sign in / Sign up

Export Citation Format

Share Document